Loading market dashboard
Adaptimmune Therapeutics plc
ADAPHealthcareNASDAQGB
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Adaptimmune Therapeutics plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $246.55M | $189.86M - $289.83M | -$211.83M | -$0.08 | 1 |
| Dec 2028 | $182.16M | $140.27M - $214.14M | -$156.51M | -$0.08 | 1 |
| Dec 2027 | $116.43M | $89.66M - $136.87M | -$100.03M | -$0.07 | 2 |
| Dec 2026 | $20.70M | $15.94M - $24.33M | -$17.78M | -$0.189 | 2 |
| Dec 2025 | $27.44M | $14.48M - $40.40M | -$23.58M | -$0.08 | 1 |
| Dec 2024 | $182.68M | $168.60M - $195.80M | -$156.95M | -$0.026 | 5 |
| Dec 2023 | $141.46M | $108.93M - $166.29M | -$121.54M | -$0.305 | 2 |
| Dec 2022 | $27.41M | $23.29M - $31.87M | -$168.80M | -$1.093 | 1 |
| Dec 2021 | $9.20M | $7.85M - $12.11M | -$9.20M | -$0.032 | 2 |
| Dec 2020 | $4.14M | $3.53M - $5.45M | -$119.19M | -$0.893 | 2 |
| Dec 2019 | $1.70M | $1.45M - $2.24M | -$133.82M | -$1.363 | 1 |
| Dec 2018 | $59.56M | $50.84M - $78.40M | -$65.48M | -$0.915 | 2 |